Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ware Olivia C
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Russell Angus C.
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Nolet Chris
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kolaja Carey OConnor
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Gangolli Julian S
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Coric Vlad
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Beraud Jill
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jordan Erica
Revance Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-JPMORGAN CHASE & CO.(2.6%)
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sjuts Dustin S
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Moxie Dwight
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schilke Tobin
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foley Mark J
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foley Mark J
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sjuts Dustin S
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Moxie Dwight
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Schilke Tobin
Revance Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Foley Mark J
Revance Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Jordan Erica
Revance Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Hollander David
No Data